Robert Harvey

Professor Robert Harvey is a Professor in Pathophysiology and Associate Dean (Research) at the University of the Sunshine Coast's School of Health. He holds a PhD in Natural Sciences (Biochemistry) from the University of Cambridge and has held prior roles at University College London (UCL), including Professor of Molecular Neuroscience and Genetics. His research focuses on neurotransmitter receptors, neurodevelopmental disorders, and invasive species management. He currently leads projects on glycine receptor proteomics, Varroa mite control, and fire ant biocides, supported by $1.8M in ARC funding.

Education: PhD (University of Cambridge), BSc (University of York). Research interests span glycine receptor dysfunction in neurological diseases, translational drug discovery, and environmental pest control. He chairs the School of Health Research Committee and serves as Field Chief Editor of Frontiers in Molecular Neuroscience. Awards include top ExpertScape rankings and international recognitions from the German Pain Society and Sertürner Society.

• Grants: ARC DP250101477 ($965k), DP250101662 ($845k)
• Key Collaborators: Prof August Smit (Vrije Universiteit Amsterdam), Prof Megan O’Mara (University of Queensland), Prof Vincent Dietemann (Swiss Bee Research Center)
• Labs/Teams: Thompson Institute, Centre for Bioinnovation, UniSC Molecular Neuroscience Group

His work bridges basic science and clinical applications, with over 195 peer-reviewed publications and 19,830 citations. Current research emphasizes glycine receptor interactome analysis, Varroa destructor pharmacology, and RIFA receptor screening platforms.